SAMRC/Wits Developmental Pathways for Health Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
DSI-NRF Centre of Excellence in Human Development, University of the Witwatersrand, Johannesburg, South Africa.
J Hum Hypertens. 2023 Jun;37(6):455-462. doi: 10.1038/s41371-022-00709-6. Epub 2022 Jun 14.
It remains unclear which paediatric hypertension clinical practice guideline (CPG) should be applied in an African population. We, therefore, aimed to compare commonly used CPG (2017 AAP, 2016 ESH, 2004 Fourth Report) developed in high-income countries for use in South African children at four paediatric ages (children: 5 years, 8 years; adolescents: 13 years, 17 years) to determine which best predicts elevated blood pressure (BP) in adulthood (22 years, 28 years). Moreover, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for each specific paediatric CPG was calculated across the age points. The 2017 AAP definition identified more children and adolescents with hypertension when compared to the 2004 Fourth Report and 2016 ESH guidelines. In computed hazards ratios, ages 8 years to 17 years, all three paediatric CPG significantly predicted the risk of elevated BP in young adulthood (p ≤ 0.032). However, sensitivity to predict elevated BP at age 22 years for all CPG was generally low (17.0%-33.0%) with higher specificity (87.4%-93.1%). Sensitivity increased at age 28 years (51.4%-70.1%), while specificity decreased (52.8%-65.1%). Both PPV and NPV at both adult age points varied widely (17.9%-79.9% and 29.3%-92.5% respectively). The performance of these paediatric CPG in terms of AUC were not optimal at both adult age points, however, the 2017 AAP definition at age 17 years met an acceptable level of performance (AUC = 0.71). Our results, therefore, highlight the need for more research to examine if an African-specific CPG would better identify high-risk children to minimise their trajectory towards adult hypertension.
目前尚不清楚在非洲人群中应该应用哪种儿科高血压临床实践指南(CPG)。因此,我们旨在比较常用于南非儿童的常用 CPG(2017 年 AAP、2016 年 ESH、2004 年第四报告),这些 CPG 是在高收入国家制定的,用于评估四个儿科年龄段(儿童:5 岁、8 岁;青少年:13 岁、17 岁)的儿童,以确定哪些 CPG 最能预测成年期(22 岁、28 岁)血压升高。此外,还计算了每个特定儿科 CPG 在各年龄点的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。与 2004 年第四报告和 2016 年 ESH 指南相比,2017 年 AAP 定义确定了更多患有高血压的儿童和青少年。在计算的风险比中,8 岁至 17 岁的所有三个儿科 CPG 均显著预测了青年期血压升高的风险(p≤0.032)。然而,所有 CPG 预测 22 岁时血压升高的敏感性普遍较低(17.0%-33.0%),特异性较高(87.4%-93.1%)。28 岁时敏感性增加(51.4%-70.1%),特异性降低(52.8%-65.1%)。两个成年年龄点的 PPV 和 NPV 差异很大(分别为 17.9%-79.9%和 29.3%-92.5%)。在两个成年年龄点,这些儿科 CPG 的 AUC 性能都不是最佳的,但是 17 岁时的 2017 年 AAP 定义达到了可接受的性能水平(AUC=0.71)。因此,我们的结果强调需要进行更多的研究,以确定非洲特定的 CPG 是否可以更好地识别高危儿童,从而最大程度地减少他们向成年高血压发展的轨迹。